Constellation Brands heads into its October 2 earnings report with the stock at $112.92 — down 14% over the past month — and a gap between price and analyst consensus that has grown more conspicuous even as the targets underneath keep falling.
Since the previous article published September 23, the target-cutting has continued. JP Morgan's Drew Levine lowered to $133 from $165 on September 25, moving to the most cautious end of a Street that is still mostly constructive on ratings. The consensus mean now rests near $163, implying over 40% upside from current levels — but every recent revision has moved that target lower, not higher. The direction of travel is clear: analysts are keeping their Buy and Outperform ratings intact while methodically reducing the numbers beneath them. Bears see that pattern as a sign the Street hasn't fully capitulated on near-term estimates. Bulls counter that the brand equity of Corona and Modelo is durable, and that the stock's price-to-earnings multiple near 9.4x prices in a significant amount of bad news already.
One angle the price action underscores is how isolated STZ's pain has been relative to peers. Over the past week, TAP fell roughly 3.4% and dropped 3.5% — both weaker, but not by the magnitude of STZ's 4.6% slide. and were essentially flat. The underperformance is company-specific, not sector-wide, which keeps the focus squarely on what the October 2 print will say about beer volume trends and the Hispanic consumer.
Short interest tells a less alarming story than the price action alone might suggest. Short interest at 5% of the free float is meaningful but not extreme, and borrow availability remains exceptionally loose — roughly 3,900% of outstanding short interest — meaning the lending market faces no squeeze pressure whatsoever. Cost to borrow has collapsed to near 0.09%, down sharply from mid-September levels above 0.40%. The ORTEX short score of 41 places STZ in the lower half of the short-pressure universe. Options positioning is actually leaning slightly bullish relative to recent norms: the put/call ratio at 0.83 is modestly below its 20-day average, a mild divergence from the cautious tone the price action implies.
The October 2 print will test whether beer segment volume and pricing can stabilise enough to arrest the cycle of estimate reductions — and whether the $113 stock has already discounted enough of the bad news to matter.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
